HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vladimir N Uversky Selected Research

M-spondin

1/2016Intrinsic disorder in spondins and some of their interacting partners.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vladimir N Uversky Research Topics

Disease

53Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 01/2002
45Parkinson Disease (Parkinson's Disease)
02/2022 - 01/2002
43Neoplasms (Cancer)
12/2022 - 05/2004
21COVID-19
10/2022 - 01/2020
20Alzheimer Disease (Alzheimer's Disease)
05/2022 - 07/2002
14Infections
07/2022 - 08/2008
12Amyloidosis
12/2021 - 02/2002
11Carcinogenesis
01/2022 - 08/2006
10Plague (Bubonic Plague)
02/2022 - 07/2002
10Synucleinopathies
01/2017 - 01/2002
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2022 - 01/2017
6Dementia (Dementias)
09/2014 - 07/2002
5Proteostasis Deficiencies
03/2021 - 10/2006
5Virus Diseases (Viral Diseases)
01/2021 - 03/2014
4Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 09/2006
4Tauopathies
01/2022 - 04/2013
4Pneumonia (Pneumonitis)
01/2022 - 11/2020
4Pathologic Processes
01/2022 - 01/2016
4Breast Neoplasms (Breast Cancer)
10/2017 - 01/2007
4Multiple System Atrophy
09/2014 - 07/2002
3Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 03/2021
3Amyloid Plaque
12/2021 - 02/2002
3Diabetes Mellitus
11/2021 - 10/2007
3Inflammation (Inflammations)
11/2021 - 06/2007
3Cataract (Cataracts)
06/2017 - 10/2007
3Human Influenza (Influenza)
06/2009 - 09/2008
2Frontotemporal Dementia (Semantic Dementia)
06/2022 - 01/2022
2Multiple Sclerosis
02/2022 - 12/2020
2Neuroblastoma
12/2021 - 01/2019
2Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2021 - 01/2020
2Thrombocytopenia (Thrombopenia)
11/2021 - 01/2021
2Venous Thrombosis (Deep-Vein Thrombosis)
11/2021 - 08/2017
2Melanoma (Melanoma, Malignant)
10/2021 - 05/2020
2Stroke (Strokes)
01/2021 - 08/2017
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2020 - 01/2017
2Porphyrias (Porphyria)
11/2019 - 01/2017
2Disease Progression
01/2019 - 01/2017
2Type 2 Diabetes Mellitus (MODY)
09/2018 - 09/2017
2Atherosclerosis
01/2018 - 01/2016
2Insulin Resistance
09/2017 - 01/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 09/2016
2Hypersensitivity (Allergy)
12/2016 - 09/2011
2Leukemia
01/2016 - 12/2015

Drug/Important Bio-Agent (IBA)

106Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2002
32alpha-SynucleinIBA
01/2017 - 01/2002
20Amyloid (Amyloid Fibrils)IBA
05/2022 - 02/2002
19Intrinsically Disordered ProteinsIBA
06/2022 - 10/2003
19SynucleinsIBA
02/2022 - 07/2002
12VaccinesIBA
10/2022 - 07/2014
12Peptides (Polypeptides)IBA
05/2022 - 01/2007
12Pharmaceutical PreparationsIBA
01/2022 - 07/2014
9CytokinesIBA
12/2022 - 11/2016
6ProteomeIBA
02/2021 - 01/2012
5InterferonsIBA
02/2022 - 12/2015
5Protein Isoforms (Isoforms)IBA
11/2016 - 06/2013
4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
4EnzymesIBA
01/2022 - 01/2017
4Amyloid beta-PeptidesIBA
12/2021 - 12/2005
4Antiviral Agents (Antivirals)IBA
01/2021 - 10/2014
4LactoferrinIBA
01/2021 - 01/2014
4Carrier Proteins (Binding Protein)IBA
09/2020 - 01/2017
4AntigensIBA
02/2019 - 07/2002
4Biological ProductsIBA
01/2018 - 07/2008
4Inosine Diphosphate (IDP)IBA
01/2016 - 01/2009
4MetalsIBA
11/2011 - 07/2003
4Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
09/2008 - 04/2002
3Transcription Factors (Transcription Factor)IBA
06/2022 - 04/2017
3IronIBA
02/2022 - 10/2007
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2022 - 01/2017
3baicaleinIBA
12/2021 - 10/2008
3LigandsIBA
09/2021 - 06/2019
3DNA (Deoxyribonucleic Acid)IBA
11/2020 - 01/2016
3PrionsIBA
01/2020 - 09/2015
3CalreticulinIBA
05/2018 - 01/2017
3Oleic Acid (Oleate)IBA
01/2018 - 05/2004
3Lactalbumin (alpha-Lactalbumin)IBA
01/2018 - 05/2004
3ChromatinIBA
01/2016 - 05/2004
2Viral ProteinsIBA
06/2022 - 02/2015
2Membrane Proteins (Integral Membrane Proteins)IBA
04/2022 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 01/2016
2AndrogensIBA
11/2021 - 01/2017
2Messenger RNA (mRNA)IBA
11/2021 - 01/2007
2AntibodiesIBA
09/2021 - 03/2021
2Viral RNAIBA
09/2021 - 01/2021
2Human Serum AlbuminFDA LinkGeneric
05/2021 - 06/2019
2Protein AggregatesIBA
03/2021 - 01/2021
2Amino AcidsFDA Link
01/2020 - 07/2002
2IonsIBA
06/2019 - 11/2011
2Molecular Chaperones (Chaperone, Molecular)IBA
01/2019 - 01/2015
2Antimicrobial PeptidesIBA
01/2019 - 01/2017
2AlbuminsIBA
01/2018 - 07/2002
2Insulin (Novolin)FDA Link
09/2017 - 03/2016
2DipeptidesIBA
06/2017 - 01/2017
2tau Proteins (tau Protein)IBA
06/2017 - 10/2013
2Lipoproteins (Lipoprotein)IBA
01/2017 - 01/2016
2Superoxide Dismutase-1IBA
01/2017 - 01/2017
2Interleukin-11 (Interleukin 11)IBA
01/2017 - 11/2016
2Profilins (Profilin)IBA
01/2017 - 01/2017
2RotenoneIBA
10/2016 - 10/2004

Therapy/Procedure

18Therapeutics
02/2022 - 10/2008